User menu

PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells.

Bibliographic reference van Baren, Nicolas ; Chambost, H. ; Ferrant, Augustin ; Michaux, Lucienne ; Ikeda, H. ; et. al. PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells.. In: British Journal of Haematology, Vol. 102, no. 5, p. 1376-9 (1998)
Permanent URL
  1. Bos, Cancer Research, 49,, 4682 (1989)
  2. Chambost H., Brasseur F., Coulie P., Plaen E., Stoppa A. M., Baume D., Mannoni P., Boon T., Maraninchi D., Olive D., A tumour-associated antigen expression in human haematological malignancies, 10.1111/j.1365-2141.1993.tb03111.x
  3. Coulie , P.G. Lehmann , F. Lethé , B. Herman , J. Lurquin , C. Andrawiss , M. Boon , T. 1995 Proceedings of the National Academy of Sciences of the United States of America 92, 7976 7980
  4. Gjertsen Marianne K., Bjørheim Jens, Saeterdal Ingvil, Myklebust June, Gaudernack Gustav, Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12VAL) peptide vaccination of a patient, recognize 12VAL-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation, 10.1002/(sici)1097-0215(19970904)72:5<784::aid-ijc14>;2-9
  5. Harris, Blood, 84,, 1361 (1994)
  6. Ikeda Hideyuki, Lethé Bernard, Lehmann Frédéric, Van Baren Nicolas, Baurain Jean-François, De Smet Charles, Chambost Hervé, Vitale Massimo, Moretta Alessandro, Boon Thierry, Coulie Pierre G, Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor, 10.1016/s1074-7613(00)80426-4
  7. Kannagi Mari, Matsushita Shuzo, Harada Shinji, Expression of the target antigen for cytotoxic T lymphocytes on adult T-cell-leukemia cells, 10.1002/ijc.2910540411
  8. Lethé, Melanoma Research, 7,, S83 (1997)
  9. Mandruzzato Susanna, Brasseur Francis, Andry Guy, Boon Thierry, Bruggen Pierre van der, A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma, 10.1084/jem.186.5.785
  10. Molldrem, Blood, 88,, 2450 (1996)
  11. Murray R. J., Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies, 10.1084/jem.176.1.157
  12. Robbins P. F., A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes, 10.1084/jem.183.3.1185
  13. MAGE-1 gene is expressed in T-cell leukemia, 10.1002/1097-0215(19960301)65:5<709::aid-ijc2910650502>;2-f
  14. ten Bosch, Blood, 88,, 3522 (1996)
  15. Van den Eynde B., A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma, 10.1084/jem.182.3.689
  16. Van den Eynde Benoît J, van der Bruggen Pierre, T cell defined tumor antigens, 10.1016/s0952-7915(97)80050-7
  17. Wolfel T., Hauer M., Schneider J., Serrano M., Wolfel C., Klehmann-Hieb E., De Plaen E., Hankeln T., Meyer zum Buschenfelde K., Beach D., A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma, 10.1126/science.7652577